nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—MTOR—blood plasma—schizophrenia	0.0351	0.104	CbGeAlD
Everolimus—FKBP1A—blood plasma—schizophrenia	0.0316	0.0935	CbGeAlD
Everolimus—CYP3A4—urine—schizophrenia	0.0198	0.0585	CbGeAlD
Everolimus—MTOR—forebrain—schizophrenia	0.0192	0.0569	CbGeAlD
Everolimus—MTOR—telencephalon—schizophrenia	0.0177	0.0524	CbGeAlD
Everolimus—FKBP1A—forebrain—schizophrenia	0.0173	0.0512	CbGeAlD
Everolimus—FKBP1A—telencephalon—schizophrenia	0.0159	0.0471	CbGeAlD
Everolimus—MTOR—gonad—schizophrenia	0.0148	0.0437	CbGeAlD
Everolimus—FKBP1A—gonad—schizophrenia	0.0133	0.0393	CbGeAlD
Everolimus—MTOR—blood—schizophrenia	0.0129	0.0381	CbGeAlD
Everolimus—FKBP1A—blood—schizophrenia	0.0116	0.0342	CbGeAlD
Everolimus—FKBP1A—midbrain—schizophrenia	0.0114	0.0338	CbGeAlD
Everolimus—MTOR—endocrine gland—schizophrenia	0.0112	0.033	CbGeAlD
Everolimus—MTOR—nervous system—schizophrenia	0.0104	0.0309	CbGeAlD
Everolimus—CYP3A4—blood plasma—schizophrenia	0.0103	0.0305	CbGeAlD
Everolimus—MTOR—central nervous system—schizophrenia	0.0101	0.0298	CbGeAlD
Everolimus—FKBP1A—endocrine gland—schizophrenia	0.01	0.0297	CbGeAlD
Everolimus—MTOR—cerebellum—schizophrenia	0.00983	0.0291	CbGeAlD
Everolimus—FKBP1A—nervous system—schizophrenia	0.00939	0.0278	CbGeAlD
Everolimus—FKBP1A—central nervous system—schizophrenia	0.00904	0.0268	CbGeAlD
Everolimus—FKBP1A—cerebellum—schizophrenia	0.00884	0.0262	CbGeAlD
Everolimus—MTOR—brain—schizophrenia	0.00798	0.0236	CbGeAlD
Everolimus—FKBP1A—brain—schizophrenia	0.00718	0.0213	CbGeAlD
Everolimus—Temsirolimus—CYP2D6—schizophrenia	0.00463	0.337	CrCbGaD
Everolimus—CYP3A4—blood—schizophrenia	0.00378	0.0112	CbGeAlD
Everolimus—Temsirolimus—ABCB1—schizophrenia	0.00331	0.24	CrCbGaD
Everolimus—CYP3A4—endocrine gland—schizophrenia	0.00328	0.00971	CbGeAlD
Everolimus—CYP3A4—nervous system—schizophrenia	0.00307	0.00909	CbGeAlD
Everolimus—CYP3A4—central nervous system—schizophrenia	0.00295	0.00875	CbGeAlD
Everolimus—Sirolimus—ABCB1—schizophrenia	0.00291	0.212	CrCbGaD
Everolimus—Tacrolimus—ABCB1—schizophrenia	0.00291	0.212	CrCbGaD
Everolimus—FKBP1A—Disease—SNAP25—schizophrenia	0.000475	0.000733	CbGpPWpGaD
Everolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—schizophrenia	0.000474	0.000731	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GFAP—schizophrenia	0.000472	0.000728	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—EP300—schizophrenia	0.000472	0.000728	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GRM5—schizophrenia	0.000467	0.00072	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—HLA-E—schizophrenia	0.00046	0.000709	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—GSK3B—schizophrenia	0.000459	0.000708	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AKT1—schizophrenia	0.000456	0.000703	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—AKT1—schizophrenia	0.000456	0.000703	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—FOS—schizophrenia	0.000456	0.000703	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TLE3—schizophrenia	0.000452	0.000698	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—TP53—schizophrenia	0.000452	0.000697	CbGpPWpGaD
Everolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—schizophrenia	0.000448	0.00069	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-E—schizophrenia	0.000442	0.000681	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PPP1R1B—schizophrenia	0.000438	0.000676	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—GSK3B—schizophrenia	0.00043	0.000664	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCK—schizophrenia	0.000427	0.000659	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HSPA1A—schizophrenia	0.000427	0.000658	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL3RA—schizophrenia	0.000426	0.000657	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS1—schizophrenia	0.000424	0.000653	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	0.00042	0.000648	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PDE4B—schizophrenia	0.000416	0.000642	CbGpPWpGaD
Everolimus—MTOR—Immune System—NRG3—schizophrenia	0.000416	0.000641	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCKAR—schizophrenia	0.00041	0.000632	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FZD3—schizophrenia	0.000408	0.000629	CbGpPWpGaD
Everolimus—MTOR—PI-3K cascade—AKT1—schizophrenia	0.000403	0.000622	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ADORA2A—schizophrenia	0.000397	0.000612	CbGpPWpGaD
Everolimus—MTOR—PI3K/AKT activation—AKT1—schizophrenia	0.000394	0.000607	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PRL—schizophrenia	0.000393	0.000606	CbGpPWpGaD
Everolimus—MTOR—GAB1 signalosome—AKT1—schizophrenia	0.00039	0.000602	CbGpPWpGaD
Everolimus—MTOR—Disease—NRG3—schizophrenia	0.000384	0.000592	CbGpPWpGaD
Everolimus—MTOR—Disease—TLE1—schizophrenia	0.000384	0.000592	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FES—schizophrenia	0.000383	0.000591	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PPP3CC—schizophrenia	0.000383	0.000591	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GRM2—schizophrenia	0.000383	0.000591	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TAAR6—schizophrenia	0.000383	0.000591	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—S100B—schizophrenia	0.000383	0.000591	CbGpPWpGaD
Everolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—schizophrenia	0.000382	0.000588	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—AKT1—schizophrenia	0.000382	0.000588	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FGA—schizophrenia	0.000381	0.000587	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—AKT1—schizophrenia	0.000376	0.00058	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NPY—schizophrenia	0.000371	0.000572	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NOTCH4—schizophrenia	0.000371	0.000572	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ATP2A2—schizophrenia	0.000371	0.000572	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—ERBB4—schizophrenia	0.000366	0.000565	CbGpPWpGaD
Everolimus—MTOR—Disease—TLE3—schizophrenia	0.000363	0.00056	CbGpPWpGaD
Everolimus—MTOR—Immune System—CAMK2B—schizophrenia	0.000362	0.000558	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—OXT—schizophrenia	0.000358	0.000552	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR1B—schizophrenia	0.000358	0.000552	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—AKT1—schizophrenia	0.000355	0.000547	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NGEF—schizophrenia	0.000355	0.000547	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—ERBB4—schizophrenia	0.000352	0.000543	CbGpPWpGaD
Everolimus—FKBP1A—Disease—ERBB4—schizophrenia	0.00035	0.00054	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	0.000347	0.000535	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NTS—schizophrenia	0.000347	0.000534	CbGpPWpGaD
Everolimus—MTOR—Disease—GAPDH—schizophrenia	0.000346	0.000534	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR1A—schizophrenia	0.000345	0.000531	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	0.000342	0.000528	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NPS—schizophrenia	0.000339	0.000523	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—NRG1—schizophrenia	0.000338	0.000521	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—TP53—schizophrenia	0.000338	0.000521	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—MEF2C—schizophrenia	0.000335	0.000517	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DRD1—schizophrenia	0.000333	0.000513	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR2C—schizophrenia	0.000333	0.000513	CbGpPWpGaD
Everolimus—MTOR—Immune System—NCAM1—schizophrenia	0.000331	0.000511	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RGS4—schizophrenia	0.000326	0.000503	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RTN4—schizophrenia	0.000326	0.000503	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GRM3—schizophrenia	0.000326	0.000503	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—NRG1—schizophrenia	0.000325	0.000501	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NTRK2—schizophrenia	0.000324	0.000499	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NRG1—schizophrenia	0.000323	0.000499	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DRD3—schizophrenia	0.000322	0.000497	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR6—schizophrenia	0.00032	0.000493	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—ERBB3—schizophrenia	0.000317	0.000489	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	0.000314	0.000484	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DRD4—schizophrenia	0.000313	0.000483	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—YWHAZ—schizophrenia	0.000311	0.00048	CbGpPWpGaD
Everolimus—FKBP1A—Disease—YWHAZ—schizophrenia	0.00031	0.000478	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	0.00031	0.000478	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MAG—schizophrenia	0.000309	0.000476	CbGpPWpGaD
Everolimus—MTOR—Disease—FGA—schizophrenia	0.000306	0.000472	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—ERBB3—schizophrenia	0.000304	0.000469	CbGpPWpGaD
Everolimus—FKBP1A—Disease—ERBB3—schizophrenia	0.000303	0.000467	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—EP300—schizophrenia	0.000302	0.000466	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—AKT1—schizophrenia	0.000301	0.000465	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CNR1—schizophrenia	0.000299	0.000461	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—AKT1—schizophrenia	0.000296	0.000457	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DRD2—schizophrenia	0.000291	0.000449	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR7—schizophrenia	0.000291	0.000449	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MTHFR—schizophrenia	0.000291	0.000449	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—AKT1—schizophrenia	0.000288	0.000445	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—AKT1—schizophrenia	0.000285	0.00044	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—AKT1—schizophrenia	0.000284	0.000438	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CHRM1—schizophrenia	0.000283	0.000436	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL3RA—schizophrenia	0.000275	0.000425	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PRL—schizophrenia	0.000275	0.000424	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—AKT1—schizophrenia	0.000272	0.00042	CbGpPWpGaD
Everolimus—FKBP1A—Disease—APOE—schizophrenia	0.000271	0.000418	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—AKT1—schizophrenia	0.000271	0.000418	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—AKT1—schizophrenia	0.00027	0.000416	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—AKT1—schizophrenia	0.00027	0.000416	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NRG3—schizophrenia	0.000269	0.000414	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TLE1—schizophrenia	0.000269	0.000414	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—AKT1—schizophrenia	0.000268	0.000414	CbGpPWpGaD
Everolimus—FKBP1A—Disease—APOA1—schizophrenia	0.000268	0.000413	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-E—schizophrenia	0.000268	0.000413	CbGpPWpGaD
Everolimus—MTOR—Disease—SNAP25—schizophrenia	0.000267	0.000412	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—AKT1—schizophrenia	0.000267	0.000412	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GFAP—schizophrenia	0.000266	0.00041	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—schizophrenia	0.000263	0.000406	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—COMT—schizophrenia	0.000263	0.000406	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GRM5—schizophrenia	0.000263	0.000405	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—GSTP1—schizophrenia	0.000262	0.000404	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—MAOA—schizophrenia	0.000261	0.000403	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	0.000259	0.0004	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	0.000258	0.000398	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—S100B—schizophrenia	0.000257	0.000396	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TLE3—schizophrenia	0.000254	0.000392	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—AKT1—schizophrenia	0.000251	0.000387	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—AKT1—schizophrenia	0.000251	0.000387	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—AKT1—schizophrenia	0.000251	0.000387	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—AKT1—schizophrenia	0.000249	0.000384	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—AKT1—schizophrenia	0.000247	0.000381	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—AKT1—schizophrenia	0.000246	0.000379	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—GSK3B—schizophrenia	0.000245	0.000379	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ERBB4—schizophrenia	0.000245	0.000378	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—FOS—schizophrenia	0.000244	0.000376	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—GSTM1—schizophrenia	0.000241	0.000371	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCK—schizophrenia	0.00024	0.00037	CbGpPWpGaD
Everolimus—MTOR—Disease—HSPA1A—schizophrenia	0.00024	0.00037	CbGpPWpGaD
Everolimus—MTOR—Immune System—PRL—schizophrenia	0.000239	0.000369	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS1—schizophrenia	0.000238	0.000367	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	0.000237	0.000366	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—GSK3B—schizophrenia	0.000236	0.000364	CbGpPWpGaD
Everolimus—FKBP1A—Disease—GSK3B—schizophrenia	0.000235	0.000362	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PDE4B—schizophrenia	0.000234	0.000361	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—AKT1—schizophrenia	0.000233	0.000359	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PLA2G4A—schizophrenia	0.000231	0.000356	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCKAR—schizophrenia	0.00023	0.000355	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NRG1—schizophrenia	0.000226	0.000349	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PRODH—schizophrenia	0.000225	0.000347	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MEF2C—schizophrenia	0.000224	0.000346	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADORA2A—schizophrenia	0.000223	0.000344	CbGpPWpGaD
Everolimus—MTOR—Immune System—S100B—schizophrenia	0.000223	0.000344	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—AKT1—schizophrenia	0.000223	0.000343	CbGpPWpGaD
Everolimus—MTOR—Disease—PRL—schizophrenia	0.000221	0.000341	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—YWHAZ—schizophrenia	0.000217	0.000334	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—TP53—schizophrenia	0.000216	0.000333	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FGA—schizophrenia	0.000214	0.00033	CbGpPWpGaD
Everolimus—MTOR—Immune System—ERBB4—schizophrenia	0.000213	0.000329	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ERBB3—schizophrenia	0.000212	0.000327	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NPY—schizophrenia	0.000209	0.000322	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ATP2A2—schizophrenia	0.000209	0.000322	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NOTCH4—schizophrenia	0.000209	0.000322	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR2A—schizophrenia	0.000204	0.000315	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR1B—schizophrenia	0.000201	0.00031	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—OXT—schizophrenia	0.000201	0.00031	CbGpPWpGaD
Everolimus—MTOR—Disease—ERBB4—schizophrenia	0.000197	0.000304	CbGpPWpGaD
Everolimus—MTOR—Immune System—NRG1—schizophrenia	0.000197	0.000304	CbGpPWpGaD
Everolimus—MTOR—Immune System—MEF2C—schizophrenia	0.000195	0.000301	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR1A—schizophrenia	0.000194	0.000299	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NPS—schizophrenia	0.000191	0.000294	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—APOE—schizophrenia	0.00019	0.000293	CbGpPWpGaD
Everolimus—MTOR—Immune System—YWHAZ—schizophrenia	0.000189	0.000291	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—APOA1—schizophrenia	0.000188	0.000289	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR2C—schizophrenia	0.000187	0.000289	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DRD1—schizophrenia	0.000187	0.000289	CbGpPWpGaD
Everolimus—MTOR—Immune System—ERBB3—schizophrenia	0.000185	0.000285	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MPC2—schizophrenia	0.000184	0.000283	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NTRK2—schizophrenia	0.000182	0.000281	CbGpPWpGaD
Everolimus—MTOR—Disease—NRG1—schizophrenia	0.000182	0.00028	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DRD3—schizophrenia	0.000181	0.00028	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ESR1—schizophrenia	0.000181	0.000279	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DRD4—schizophrenia	0.000176	0.000271	CbGpPWpGaD
Everolimus—MTOR—Disease—YWHAZ—schizophrenia	0.000174	0.000269	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—AKT1—schizophrenia	0.000171	0.000264	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLCH2—schizophrenia	0.000171	0.000263	CbGpPWpGaD
Everolimus—MTOR—Disease—ERBB3—schizophrenia	0.00017	0.000263	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CNR1—schizophrenia	0.000168	0.000259	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GSK3B—schizophrenia	0.000164	0.000253	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR7—schizophrenia	0.000164	0.000253	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DRD2—schizophrenia	0.000164	0.000253	CbGpPWpGaD
Everolimus—MTOR—Disease—MTHFR—schizophrenia	0.000164	0.000252	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—EP300—schizophrenia	0.000162	0.000249	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—NDST3—schizophrenia	0.00016	0.000247	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRL—schizophrenia	0.000155	0.000239	CbGpPWpGaD
Everolimus—FKBP1A—Disease—EP300—schizophrenia	0.000154	0.000238	CbGpPWpGaD
Everolimus—MTOR—Disease—APOE—schizophrenia	0.000152	0.000235	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ACSL6—schizophrenia	0.000152	0.000235	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC27A5—schizophrenia	0.000152	0.000235	CbGpPWpGaD
Everolimus—MTOR—Disease—APOA1—schizophrenia	0.000151	0.000232	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DAO—schizophrenia	0.000145	0.000224	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—S100B—schizophrenia	0.000144	0.000222	CbGpPWpGaD
Everolimus—MTOR—Immune System—GSK3B—schizophrenia	0.000143	0.00022	CbGpPWpGaD
Everolimus—MTOR—Immune System—FOS—schizophrenia	0.000142	0.000219	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PNP—schizophrenia	0.000139	0.000214	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ERBB4—schizophrenia	0.000138	0.000213	CbGpPWpGaD
Everolimus—MTOR—Disease—GSK3B—schizophrenia	0.000132	0.000204	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PLA2G4A—schizophrenia	0.00013	0.0002	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—NDUFV2—schizophrenia	0.000129	0.000199	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NRG1—schizophrenia	0.000127	0.000196	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MEF2C—schizophrenia	0.000126	0.000195	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—YWHAZ—schizophrenia	0.000122	0.000188	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PIP4K2A—schizophrenia	0.000122	0.000187	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ERBB3—schizophrenia	0.000119	0.000184	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR2A—schizophrenia	0.000115	0.000177	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP26B1—schizophrenia	0.00011	0.00017	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—EP300—schizophrenia	0.000108	0.000167	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOE—schizophrenia	0.000107	0.000165	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOA1—schizophrenia	0.000106	0.000163	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1B—schizophrenia	0.000105	0.000162	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ESR1—schizophrenia	0.000102	0.000157	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TPH1—schizophrenia	9.8e-05	0.000151	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GCLM—schizophrenia	9.8e-05	0.000151	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—AKT1—schizophrenia	9.76e-05	0.000151	CbGpPWpGaD
Everolimus—MTOR—Immune System—EP300—schizophrenia	9.41e-05	0.000145	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—AKT1—schizophrenia	9.37e-05	0.000145	CbGpPWpGaD
Everolimus—FKBP1A—Disease—AKT1—schizophrenia	9.33e-05	0.000144	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GSK3B—schizophrenia	9.24e-05	0.000143	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PRKD1—schizophrenia	9.21e-05	0.000142	CbGpPWpGaD
Everolimus—MTOR—Disease—EP300—schizophrenia	8.69e-05	0.000134	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TP53—schizophrenia	7.74e-05	0.000119	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GAPDH—schizophrenia	7.69e-05	0.000119	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CLOCK—schizophrenia	7.62e-05	0.000118	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TPH2—schizophrenia	7.43e-05	0.000115	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CACNB2—schizophrenia	7.43e-05	0.000115	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DPYD—schizophrenia	7.31e-05	0.000113	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CACNA1C—schizophrenia	6.79e-05	0.000105	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PIK3C2A—schizophrenia	6.62e-05	0.000102	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AKT1—schizophrenia	6.54e-05	0.000101	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EP300—schizophrenia	6.08e-05	9.38e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP2D6—schizophrenia	5.94e-05	9.16e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SNAP25—schizophrenia	5.94e-05	9.16e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—AKT1—schizophrenia	5.69e-05	8.77e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP1A2—schizophrenia	5.37e-05	8.28e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TH—schizophrenia	5.29e-05	8.16e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—AKT1—schizophrenia	5.25e-05	8.09e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—COMT—schizophrenia	4.5e-05	6.94e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTP1—schizophrenia	4.48e-05	6.91e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MAOA—schizophrenia	4.47e-05	6.89e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TP53—schizophrenia	4.35e-05	6.71e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCB1—schizophrenia	4.24e-05	6.54e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTM1—schizophrenia	4.12e-05	6.35e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLA2G4A—schizophrenia	4.12e-05	6.35e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AKT1—schizophrenia	3.68e-05	5.67e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MTHFR—schizophrenia	3.64e-05	5.61e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOE—schizophrenia	3.39e-05	5.22e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOA1—schizophrenia	3.35e-05	5.16e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—EP300—schizophrenia	1.93e-05	2.98e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AKT1—schizophrenia	1.17e-05	1.8e-05	CbGpPWpGaD
